Circulating markers of inflammation and their link to indices of adiposity

Obesity Facts

Volumn 1, Issue 5, 2008, Pages 259-265

  Browning, Lucy M ^a   Krebs, Jeremy D ^a   Magee, Edel C ^a   Frühbeck, Gema ^b   Jebb, Susan A ^a  

^a MRC HUMAN NUTRITION RESEARCH   (United Kingdom)

^b UNIVERSITY CLINIC OF NAVARRA   (Spain)

Author keywords

Adipokines; Cytokines; Inflammation; Metabolic syndrome; Metabolism; Obesity

Indexed keywords

BIOLOGICAL MARKER; C REACTIVE PROTEIN; CCL2 PROTEIN, HUMAN; IL6 PROTEIN, HUMAN; INTERLEUKIN 6; MONOCYTE CHEMOTACTIC PROTEIN 1; TUMOR NECROSIS FACTOR ALPHA;

ADIPOSE TISSUE; ADULT; AGED; ARTICLE; BLOOD; BODY MASS; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DIET THERAPY; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMAN; IMMUNOLOGY; LOW CALORY DIET; METABOLIC SYNDROME X; METABOLISM; MIDDLE AGED; OBESITY; RANDOMIZED CONTROLLED TRIAL; TREATMENT OUTCOME; WEIGHT REDUCTION;

ADIPOSE TISSUE; ADULT; AGED; BIOLOGICAL MARKERS; BODY MASS INDEX; C-REACTIVE PROTEIN; CHEMOKINE CCL2; DIET, REDUCING; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMANS; INTERLEUKIN-6; METABOLIC SYNDROME X; MIDDLE AGED; OBESITY; TREATMENT OUTCOME; TUMOR NECROSIS FACTOR-ALPHA; WEIGHT LOSS; YOUNG ADULT;

EID: 67650048483     PISSN: 16624025     EISSN: 16624033     Source Type: Journal    
DOI: 10.1159/000169832     Document Type: Article

References (27)

1. Kern PA, Ranganathan S, Li C, Wood L, Ranga -nathan G: Adipose tissue tumor necrosis factor and interleukin-6 expression in human obesity and insulin resistance. Am J Physiol Endocrinol Metab 2001;280:E745-751.
2. Tsigos C, Kyrou I, Chala E, Tsapogas P, Stavridis JC, Raptis SA, Katsilambros N: Circulating tumor necrosis factor alpha concentrations are higher in abdominal versus peripheral obesity. Metabolism 1999;48:1332-1335. (Pubitemid 29496085)
3. Browning LM, Jebb SA, Mishra GD, Cooke JH, O'Connell MA, Crook MA, Krebs JD: Elevated sialic acid, but not CRP, predicts features of the metabolic syndrome independently of BMI in women. Int J Obes 2004;28:1004-1010. (Pubitemid 38998706)
4. Hotamisligil GS, Shargill NS, Spiegelman BM: Adipose expression of tumor necrosis factor-alpha: direct role in obesity-linked insulin resistance. Science 1993;259:87-91. (Pubitemid 23036092)
5. Fried SK, Bunkin DA, Greenberg AS: Omental and subcutaneous adipose tissues of obese subjects release interleukin-6: depot difference and regulation by glucocorticoid. J Clin Endocrinol Metab 1998; 83:847-850. (Pubitemid 28496456)
6. Wellen KE, Hotamisligil GS: Obesity-induced inflammatory changes in adipose tissue. J Clin Invest 2003;112:1785-1788. (Pubitemid 38063699)
7. Weisberg SP, McCann D, Desai M, Rosenbaum M, Leibel RL, Ferrante AW Jr: Obesity is associated with macrophage accumulation in adipose tissue. J Clin Invest 2003;112:1796-1808. (Pubitemid 38063703)
8. Cancello R, Henegar C, Viguerie N, Taleb S, Poitou C, Rouault C, Coupaye M, Pelloux V, Hugol D, Bouillot JL, Bouloumie A, Barbatelli G, Cinti S, Svensson PA, Barsh GS, Zucker JD, Basdevant A, Langin D, Clement K: Reduction of macrophage infiltration and chemoattractant gene expression changes in white adipose tissue of morbidly obese subjects after surgery-induced weight loss. Diabetes 2005;54:2277-2286. (Pubitemid 41134253)
9. Bastard J-P, Jardel C, Bruckert E, Blondy P, Capeau J, Laville M, Vidal H, Hainque B: Elevated levels of interleukin-6 are reduced in serum and subcutaneous adipose tissue of obese women after weight loss. J Clin Endocrinol Metab 2000;85:3338-3342.
10. Heilbronn LK, Noakes M, Clifton PM: Energy restriction and weight loss on very-low-fat diets reduce C-reactive protein concentrations in obese, healthy women. Arterioscler Thromb Vasc Biol 2001;21:968-970. (Pubitemid 34168654)
11. Ziccardi P, Nappo F, Giugliano G, Esposito K, Mar-fella R, Cioffi M, D'Andrea F, Molinari AM, Giugliano D: Reduction of inflammatory cytokine concentrations and improvement of endothelial functions in obese women after weight loss over one year. Circulation 2002;105:804-809. (Pubitemid 34174919)
12. Laimer M, Ebenbichler CF, Kaser S, Sandhofer A, Weiss H, Nehoda H, Aigner F, Patsch JR: Markers of chronic inflammation and obesity: a prospective study on the reversibility of this association in middle-aged women undergoing weight loss by surgical intervention. Int J Obes Relat Metab Disord 2002;26:659-662. (Pubitemid 34499286)
13. Krebs JD, Evans S, Cooney L, Mishra GD, Fruh-beck G, Finer N, Jebb SA: Changes in risk factors for cardiovascular disease with body fat loss in obese women. Diabetes Obes Metab 2002;4: 379-387. (Pubitemid 35345450)
14. Case CC, Jones PH, Nelson K, O'Brian Smith E, Ballantyne CM: Impact of weight loss on the metabolic syndrome. Diabetes Obes Metab 2002;4: 407-414. (Pubitemid 35345455)
15. Pereira JA, Lazarin MA, Pareja JC, de Souza A, Muscelli E: Insulin resistance in nondiabetic morbidly obese patients: effect of bariatric surgery. Obes Res 2003;11:1495-1501. (Pubitemid 41127334)
16. Christiansen T, Richelsen B, Bruun JM: Monocyte chemoattractant protein-1 is produced in isolated adipocytes, associated with adiposity and reduced after weight loss in morbid obese subjects. Int J Obes (Lond) 2005;29:146-150. (Pubitemid 40065478)
17. Krebs JD, Browning LM, McLean NK, Rothwell JL, Mishra GD, Moore CS, Jebb SA: Additive benefits of long chain n-3 polyunsaturated fatty acids and weight-loss in the management of cardiovascular disease risk in overweight hyperinsulinaemic women. Int J Obes 2006;30:1535-1544. (Pubitemid 44470203)
18. Kim CS, Park HS, Kawada T, Kim JH, Lim D, Hubbard NE, Kwon BS, Erickson KL, Yu R: Circulating levels of MCP-1 and IL-8 are elevated in human obese subjects and associated with obesity-related parameters. Int J Obes (Lond) 2006;30:1347-1355. (Pubitemid 44306516)
19. Dahlman I, Kaaman M, Olsson T, Tan GD, Bicker-ton AS, Wahlen K, Andersson J, Nordstrom EA, Blomqvist L, Sjogren A, Forsgren M, Attersand A, Arner P: A unique role of monocyte chemoattrac-tant protein 1 among chemokines in adipose tissue of obese subjects. J Clin Endocrinol Metab 2005;90 :5834-5840. (Pubitemid 41415500)
20. Bruun JM, Lihn AS, Pedersen SB, Richelsen B: Monocyte chemoattractant protein-1 release is higher in visceral than subcutaneous human adipose tissue (AT): implication of macrophages resident in the AT. J Clin Endocrinol Metab 2005;90: 2282-2289. (Pubitemid 40586275)
21. Mohamed-Ali V, Goodrick S, Rawesh A, Katz DR, Miles JM, Yudkin JS, Klein S, Coppack SW: Subcutaneous adipose tissue releases interleukin-6, but not tumor necrosis factor-alpha, in vivo. J Clin Endocrinol Metab 1997;82:4196-4200. (Pubitemid 27525539)
22. Visser M, Bouter LM, McQuillan GM, Wener MH, Harris TB: Elevated C-reactive protein levels in overweight and obese adults. JAMA 1999;282: 2131-2135.
23. Pannacciulli N, Cantatore FP, Minenna A, Bellacic-co M, Giorgino R, De Pergola G: C-reactive protein is independently associated with total body fat, central fat, and insulin resistance in adult women. Int J Obes Relat Metab Disord 2001;25:1416-1420. (Pubitemid 32977856)
24. Harris TB, Ferrucci L, Tracy RP, Corti MC, Wacholder S, Ettinger WH Jr, Heimovitz H, Cohen HJ, Wallace R: Associations of elevated interleukin-6 and C-reactive protein levels with mortality in the elderly. Am J Med 1999;106:506-512. (Pubitemid 29231100)
25. Ridker PM, Hennekens CH, Burling JE, Rifai N: C-Reactive protein and other markers of inflammation in the prediction of cardiovascular disease in women. N Engl J Med 2000;342:836-843. (Pubitemid 30165206)
26. Pradhan AD, Manson JE, Rifai N, Buring JE, Ridker PM: C-reactive protein, interleukin 6, and risk of developing type 2 diabetes mellitus. JAMA 2001; 286:327-334. (Pubitemid 32656163)
27. Freeman DJ, Norrie J, Caslake MJ, Gaw A, Ford I, Lowe GD, O'Reilly DS, Packard CJ, Sattar N: C-reactive protein is an independent predictor of risk for the development of diabetes in the West of Scotland Coronary Prevention Study. Diabetes 2002;51:1596-1600. (Pubitemid 34826630)